| Literature DB >> 34193602 |
Rashmi Tippalagama1, Akul Singhania1, Paige Dubelko1, Cecilia S Lindestam Arlehamn1, Austin Crinklaw1, Mikhail Pomaznoy1, Gregory Seumois1, Aruna D deSilva1,2, Sunil Premawansa3, Dhammika Vidanagama4, Bandu Gunasena5, N D Suraj Goonawardhana2, Dinuka Ariyaratne2, Thomas J Scriba6, Robert H Gilman7,8, Mayuko Saito9, Randy Taplitz10, Pandurangan Vijayanand1,11, Alessandro Sette1,11, Bjoern Peters12,11, Julie G Burel12.
Abstract
Upon Ag encounter, T cells can rapidly divide and form an effector population, which plays an important role in fighting acute infections. In humans, little is known about the molecular markers that distinguish such effector cells from other T cell populations. To address this, we investigated the molecular profile of T cells present in individuals with active tuberculosis (ATB), where we expect Ag encounter and expansion of effector cells to occur at higher frequency in contrast to Mycobacterium tuberculosis-sensitized healthy IGRA+ individuals. We found that the frequency of HLA-DR+ cells was increased in circulating CD4 T cells of ATB patients, and was dominantly expressed in M. tuberculosis Ag-specific CD4 T cells. We tested and confirmed that HLA-DR is a marker of recently divided CD4 T cells upon M. tuberculosis Ag exposure using an in vitro model examining the response of resting memory T cells from healthy IGRA+ to Ags. Thus, HLA-DR marks a CD4 T cell population that can be directly detected ex vivo in human peripheral blood, whose frequency is increased during ATB disease and contains recently divided Ag-specific effector T cells. These findings will facilitate the monitoring and study of disease-specific effector T cell responses in the context of ATB and other infections.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34193602 PMCID: PMC8516689 DOI: 10.4049/jimmunol.2100011
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422